(VIANEWS) – CRISPR Therapeutics AG (CRSP), Towers Watson & Co (TW), Watsco (WSO) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. CRISPR Therapeutics AG (CRSP)

500% sales growth and 25.41% return on equity

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases.

CRISPR Therapeutics AG’s sales growth this year is anticipated to be 113760% and a negative 94% for next year.

Year-on-year quarterly revenue growth grew by 2046950%, now sitting on 901.76M for the twelve trailing months.

Volume

Today’s last reported volume for CRISPR Therapeutics AG is 1785360 which is 64.45% above its average volume of 1085660.

CRISPR Therapeutics AG’s sales growth for the next quarter is 500%. The company’s growth estimates for the present quarter and the next is a negative 31.8% and negative -19.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.41%.

Volatility

CRISPR Therapeutics AG’s last day, last week, and last month’s current volatility was 2.05%, 1.60%, and 2.46%, respectively.

CRISPR Therapeutics AG’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.70% (day), 4.33% (last week), and 4.17% (last month), respectively.

CRISPR Therapeutics AG’s Stock Yearly Top and Bottom Value

CRISPR Therapeutics AG’s stock is valued at $100.65 at 01:22 EST, way under its 52-week high of $220.20 and way above its 52-week low of $84.38.

CRISPR Therapeutics AG’s Moving Average

CRISPR Therapeutics AG’s value is way under its 50-day moving average of $117.06 and way under its 200-day moving average of $122.47.

Previous days news about CRISPR Therapeutics AG(CRSP)

  • According to Benzinga on Thursday, 14 October, "To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. "

2. Towers Watson & Co (TW)

16.5% sales growth and 5.21% return on equity

Tradeweb Markets Inc. builds and operates electronic marketplaces in the United States, Europe, Asia, and internationally.

Towers Watson & Co’s sales growth this year is expected to be 19.6% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 23%, now sitting on 979.05M for the twelve trailing months.

Volume

Today’s last reported volume for Towers Watson & Co is 208621 which is 36.78% below its average volume of 330033.

Towers Watson & Co’s sales growth for the next quarter is 16.5%. The company’s growth estimates for the current quarter and the next is 26.7% and 20.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.21%.

Volatility

Towers Watson & Co’s last day, last week, and last month’s current volatility was 0.43%, 1.22%, and 1.24%, respectively.

Towers Watson & Co’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.51% (day), 2.45% (last week), and 2.10% (last month), respectively.

Towers Watson & Co’s Stock Yearly Top and Bottom Value

Towers Watson & Co’s stock is valued at $83.48 at 01:22 EST, below its 52-week high of $89.79 and way above its 52-week low of $53.81.

Towers Watson & Co’s Moving Average

Towers Watson & Co’s worth is below its 50-day moving average of $84.56 and below its 200-day moving average of $83.65.

3. Watsco (WSO)

15.3% sales growth and 22.95% return on equity

Watsco, Inc., together with its subsidiaries, distributes air conditioning, heating, and refrigeration equipment; and related parts and supplies in the United States, Canada, Mexico, and Puerto Rico.

Watsco’s sales growth this year is expected to be 21.4% and 3.6% for next year.

Year-on-year quarterly revenue growth grew by 36.5%, now sitting on 5.68B for the twelve trailing months.

Volume

Today’s last reported volume for Watsco is 114802 which is 16.96% below its average volume of 138261.

Watsco’s sales growth for the next quarter is 15.3%. The company’s growth estimates for the ongoing quarter and the next is 26.1% and 38.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.95%.

Volatility

Watsco’s last day, last week, and last month’s current volatility was 1.66%, 0.89%, and 1.09%, respectively.

Watsco’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.54% (day), 1.33% (last week), and 1.60% (last month), respectively.

Watsco’s Stock Yearly Top and Bottom Value

Watsco’s stock is valued at $282.97 at 01:22 EST, below its 52-week high of $307.81 and way above its 52-week low of $216.25.

Watsco’s Moving Average

Watsco’s value is above its 50-day moving average of $276.89 and higher than its 200-day moving average of $282.13.

4. Gaia (GAIA)

14.9% sales growth and 10.63% return on equity

Gaia, Inc. operates a digital video subscription service and on-line community for underserved member base in the United States, Canada, Australia, and internationally.

Gaia’s sales growth this year is expected to be 19.9% and 15.7% for next year.

Year-on-year quarterly revenue growth grew by 20.4%, now sitting on 74.5M for the twelve trailing months.

Volume

Today’s last reported volume for Gaia is 32884 which is 47.97% below its average volume of 63209.

Gaia’s sales growth for the next quarter is 14.9%. The company’s growth estimates for the present quarter and the next is a negative 90.6% and 50%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.63%.

Volatility

Gaia’s last day, last week, and last month’s current volatility was 1.28%, 0.87%, and 1.71%, respectively.

Gaia’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.92% (day), 3.19% (last week), and 4.41% (last month), respectively.

Gaia’s Stock Yearly Top and Bottom Value

Gaia’s stock is valued at $9.47 at 01:22 EST, way under its 52-week high of $15.06 and above its 52-week low of $8.91.

Gaia’s Moving Average

Gaia’s worth is below its 50-day moving average of $9.70 and way under its 200-day moving average of $10.85.

5. Genesco (GCO)

12.5% sales growth and 22.36% return on equity

Genesco Inc. operates as a retailer and wholesaler of footwear, apparel, and accessories.

Genesco’s sales growth this year is anticipated to be 33.5% and 2.6% for next year.

Year-on-year quarterly revenue growth grew by 41.9%, now sitting on 2.21B for the twelve trailing months.

Volume

Today’s last reported volume for Genesco is 105918 which is 13.5% below its average volume of 122453.

Genesco’s sales growth is a negative 0% for the present quarter and 12.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 51.8% and negative -2.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.36%.

Volatility

Genesco’s last day, last week, and last month’s current volatility was 2.74%, 3.36%, and 2.66%, respectively.

Genesco’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.46% (day), 3.93% (last week), and 4.28% (last month), respectively.

Genesco’s Stock Yearly Top and Bottom Value

Genesco’s stock is valued at $59.25 at 01:22 EST, way below its 52-week high of $67.26 and way higher than its 52-week low of $17.54.

Genesco’s Moving Average

Genesco’s value is under its 50-day moving average of $60.09 and above its 200-day moving average of $56.80.

6. Kinder Morgan (KMI)

6.8% sales growth and 5.61% return on equity

Kinder Morgan, Inc. operates as an energy infrastructure company in North America.

Kinder Morgan’s sales growth this year is anticipated to be 25.9% and a negative 12.1% for next year.

Year-on-year quarterly revenue growth grew by 67.8%, now sitting on 13.8B for the twelve trailing months.

Volume

Today’s last reported volume for Kinder Morgan is 11632000 which is 18.09% below its average volume of 14201000.

Kinder Morgan’s sales growth for the next quarter is 6.8%. The company’s growth estimates for the current quarter and the next is 14.3% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.61%.

Volatility

Kinder Morgan’s last day, last week, and last month’s current volatility was 2.28%, 1.65%, and 1.13%, respectively.

Kinder Morgan’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.38% (day), 2.24% (last week), and 2.08% (last month), respectively.

Kinder Morgan’s Stock Yearly Top and Bottom Value

Kinder Morgan’s stock is valued at $18.46 at 01:22 EST, under its 52-week high of $19.29 and way higher than its 52-week low of $11.45.

Kinder Morgan’s Moving Average

Kinder Morgan’s value is way above its 50-day moving average of $16.61 and higher than its 200-day moving average of $17.39.

Previous days news about Kinder Morgan(KMI)

  • According to Bloomberg Quint on Tuesday, 12 October, "The methane appeared to be above a gas well operated by Hilcorp Energy Co. as well as near gas pipelines operated by companies including Enterprise Products Partners LP and Kinder Morgan Inc. There are also coal mines in the area that could be a source of the plume, Kayrros said."

7. Allied Motion Technologies (AMOT)

6% sales growth and 16.37% return on equity

Allied Motion Technologies Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems that are used in a range of industries worldwide.

Allied Motion Technologies’s sales growth this year is expected to be 10.3% and 7.5% for next year.

Year-on-year quarterly revenue growth grew by 17.2%, now sitting on 390.86M for the twelve trailing months.

Volume

Today’s last reported volume for Allied Motion Technologies is 4644 which is 84.19% below its average volume of 29390.

Allied Motion Technologies’s sales growth is a negative 0% for the ongoing quarter and 6% for the next. The company’s growth estimates for the present quarter and the next is 10.7% and 36.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.37%.

Volatility

Allied Motion Technologies’s last day, last week, and last month’s current volatility was 0.65%, 0.75%, and 2.20%, respectively.

Allied Motion Technologies’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.91% (day), 3.02% (last week), and 4.14% (last month), respectively.

Allied Motion Technologies’s Stock Yearly Top and Bottom Value

Allied Motion Technologies’s stock is valued at $32.79 at 01:22 EST, way below its 52-week high of $38.10 and way higher than its 52-week low of $25.02.

Allied Motion Technologies’s Moving Average

Allied Motion Technologies’s worth is above its 50-day moving average of $32.42 and below its 200-day moving average of $33.85.

LEAVE A REPLY

Please enter your comment!
Please enter your name here